Skip to content
Faron, etusivu
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Forecasts and analysis, Analysts
Outlook
Share and shareholders
Share information
Shareholders
Share monitor
Management ownership and transactions
Warrants
Public offering 2024
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Forecasts and analysis, Analysts
Outlook
Share and shareholders
Share information
Shareholders
Share monitor
Management ownership and transactions
Warrants
Public offering 2024
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
releases and publications
Category
All
Company announcements
Press releases
Managers' transactions
Flagging notifications
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
24.06.2024
Holding(s) in Company
Shareholder announcement
Regulatory
24.06.2024
Holding(s) in Company
Shareholder announcement
Regulatory
24.06.2024
Holding(s) in Company
Shareholder announcement
Regulatory
24.06.2024
Holding(s) in Company
Shareholder announcement
Regulatory
20.06.2024
New shares registered with Finnish Trade Register
Regulatory
20.06.2024
Fully subscribed EUR 30.7 million share offering
Regulatory
05.06.2024
Proposed REX Retail Offer
Regulatory
04.06.2024
Faron commences a share offering
Regulatory
20.05.2024
Initial positive data from Phase 2 of BEXMAB
Regulatory
17.05.2024
Issuance of warrants
Regulatory
Previous
Next
Back to top
